Although numerous studies have used CEA levels to predict stage, tumor progression, recurrence, and prognosis in gastric cancer [26], this marker has limited clinical utility due to its low specificity and sensitivity [27]. This evidence concerns the gene CEACAM5 and gastric cancer.